世界中医药2024,Vol.19Issue(20) :3203-3210.DOI:10.3969/j.issn.1673-7202.2024.20.024

中医药调控肺肠黏膜免疫系统治疗慢性阻塞性肺疾病的研究进展

Research Progress in Traditional Chinese Medicine Regulation of the Lung-intestine Mucosal Immune System for the Treatment of Chronic Obstructive Pulmonary Disease

王卫 朱邵晴 张元斌 王曼 褚琳 杨欢 郁红礼
世界中医药2024,Vol.19Issue(20) :3203-3210.DOI:10.3969/j.issn.1673-7202.2024.20.024

中医药调控肺肠黏膜免疫系统治疗慢性阻塞性肺疾病的研究进展

Research Progress in Traditional Chinese Medicine Regulation of the Lung-intestine Mucosal Immune System for the Treatment of Chronic Obstructive Pulmonary Disease

王卫 1朱邵晴 2张元斌 3王曼 4褚琳 1杨欢 1郁红礼5
扫码查看

作者信息

  • 1. 江苏大学药学院,镇江,212013
  • 2. 镇江市高等专科学校医药技术学院,镇江,212028;镇江市功能化学重点实验室,镇江,212028
  • 3. 宁波大学附属第一医院药学部,宁波,315010
  • 4. 江苏大学附属第一人民医院,镇江,212000
  • 5. 南京中医药大学药学院,南京,210023
  • 折叠

摘要

慢性阻塞性肺疾病(COPD)是常见的肺部疾病,症多见呼吸困难、慢性咳嗽、气道炎症反应.近年来中医药在治疗呼吸系统疾病方面取得了显著进展,其在调控肺肠黏膜免疫系统方面具有长足的潜力,对COPD的治疗具有重要意义.特别是黏膜淋巴细胞迁移归巢机制介导的肺肠信号转导显示出肺肠密切的关联性,靶向肺肠黏膜免疫系统是治疗肺系疾病新的有效途径.故通过综述肺肠黏膜免疫应答调节机制,以及近年来中医药调控肺肠黏膜免疫系统治疗COPD的研究进展,研究发现中医药可通过拮抗气道和肺部炎症反应干预COPD,通过调节固有淋巴细胞(ILC)、辅助性T细胞17(Th17)免疫应答,修复黏膜屏障,以及通过调节肺肠黏膜淋巴细胞迁移归巢等途径干预COPD.为进一步探索与应用中医药治疗COPD和其他肺系疾病提供参考依据,也为深入的临床开发和机制研究提供基础和方向.

Abstract

Chronic obstructive pulmonary disease(COPD)is a common lung condition characterized by symptoms such as dyspne-a,chronic cough,and airway inflammatory responses.In recent years,traditional Chinese medicine(TCM)has made significant pro-gress in treating respiratory diseases,demonstrating considerable potential in modulating the pulmonary-gut mucosal immune sys-tem,which is crucial for COPD treatment.Particularly,pulmonary-gut signal transduction mediated by the mechanisms of mucosal lymphocyte migration and homing highlights the close relationship between the lungs and the gut,suggesting that targeting the pul-monary-gut mucosal immune system is a new effective approach for treating lung diseases.This review discussed the regulatory mechanisms of pulmonary-gut mucosal immune responses and recent research advancements in TCM modulation of this system in COPD treatment.Findings indicate that TCM can intervene in COPD by antagonizing airway and lung inflammatory responses,regu-lating innate lymphoid cells(ILCs)and T helper 17(Th17)immune responses,repairing the mucosal barrier,and adjusting the mi-gration and homing of pulmonary-gut mucosal lymphocytes.This research provides a reference for further exploration and application of TCM in treating COPD and other lung diseases,as well as foundational insights and directions for in-depth clinical development and mechanistic studies.

关键词

慢性阻塞性肺疾病/黏膜免疫系统/中药/活性成分/天然淋巴细胞/辅助性T细胞17/归巢/炎症反应

Key words

Chronic obstructive pulmonary disease/Mucosal immune system/Chinese medicine/Active ingredients/Innate lymphoid cells/Helper T cell 17/Homing/Inflammatory response

引用本文复制引用

出版年

2024
世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子:1.266
ISSN:1673-7202
段落导航相关论文